🇺🇸 FDA
Drug

selinexor

Brand: XPOVIO

approved

Quick answer

selinexor (XPOVIO), is a pharmaceutical active ingredient, associated with Karyopharm Therapeutics, with approved status in the US.

Key facts

INN
selinexor
Brand
XPOVIO
Route
ORAL
Formulation
TABLET
Originator
Karyopharm Therapeutics

Related patents

patent

US 12371420

Polymorphs of Selinexor

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11807629

Polymorphs of Selinexor

Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11753401

Polymorphs of Selinexor

Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11746102

Polymorphs of selinexor

Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11078190

Polymorphs of selinexor

Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10519139

Polymorphs of Selinexor

Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is selinexor?

selinexor (XPOVIO), is a pharmaceutical active ingredient, associated with Karyopharm Therapeutics, with approved status in the US.

What is the brand name for selinexor?

XPOVIO is a marketed brand name for selinexor. Check FDA Drugs@FDA for the current US label holder.